NRC Health Retained Earnings
NRC Health (NRC) had Retained Earnings of -$24.51 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$24.51M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$17.68M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$17.30M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$15.47M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$24.51M 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$17.68M 10-Q · filed 2026-05-06 |
| 2025-12-31 | -$17.30M 10-Q · filed 2026-08-04 |
| 2025-09-30 | -$15.47M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$16.89M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$14.01M 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$17.06M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$20.86M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$23.73M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$27.04M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$30.53M 10-K · filed 2025-03-17 |
| 2023-09-30 | -$36.48M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$16.85M 10-Q · filed 2023-08-04 |
| 2023-03-31 | -$21.17M 10-Q · filed 2023-05-05 |
| 2022-12-31 | -$25.18M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$28.87M 10-Q · filed 2022-11-04 |
| 2022-06-30 | -$31.24M 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$33.62M 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$36.11M 10-K · filed 2023-03-03 |
| 2021-09-30 | -$42.70M 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$49.30M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$52.14M 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$61.38M 10-K · filed 2022-03-04 |
| 2020-09-30 | -$69.59M 10-Q · filed 2020-11-06 |
| 2020-06-30 | -$79.17M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$86.88M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$93.36M 10-K · filed 2021-03-05 |
| 2019-09-30 | -$96.82M 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$100.20M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$102.87M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$106.34M 10-K · filed 2020-03-06 |
| 2018-09-30 | -$97.03M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$99.81M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $83.39M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $77.57M 10-K · filed 2019-03-08 |
| 2017-09-30 | $75.28M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $75.34M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $73.81M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $71.51M 10-K · filed 2018-03-14 |
| 2016-09-30 | $70.00M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $68.64M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $67.12M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $65.31M 10-K · filed 2017-03-03 |
| 2015-09-30 | $77.83M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $76.20M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $74.65M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $73.69M 10-K · filed 2016-03-04 |
| 2014-09-30 | $72.10M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $67.55M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $63.49M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $58.04M 10-K · filed 2015-03-04 |
| 2013-09-30 | $54.27M 10-Q · filed 2013-11-07 |
| 2013-03-31 | $47.03M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $44.70M 10-K · filed 2014-03-04 |
| 2012-09-30 | $53.06M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $51.26M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $49.08M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $46.99M 10-K · filed 2013-03-01 |
| 2011-09-30 | $45.34M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $44.17M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $41.34M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |